$0.68
0.15%
Nasdaq, Sep 25, 04:09 pm EDT. Closed.
ISIN
US59564R2031
Symbol
BDRX

Midatech Pharma Plc Sponsored ADR Stock price

$0.68
-0.50 42.71% 1M
-2.78 80.43% 6M
-10.67 94.04% YTD
-32.37 97.95% 1Y
-7,186.82 99.99% 3Y
-3,789,999.32 100.00% 5Y
-326,999,999.32 100.00% 10Y
-734,999,999.32 100.00% 20Y
Nasdaq, Closing price Fri, Sep 25 2026
+0.00 0.15%
ISIN
US59564R2031
Symbol
BDRX
Industry

Is Midatech Pharma Plc Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$690.0k
Enterprise Value
$-3.6m
Net debt
positive
Cash
$4.3m
Shares outstanding
7.5b
Valuation (TTM | estimate)
P/E
-
P/S
- | -
EV/Sales
- | -
EV/FCF
0.3
P/B
0.1
Financial Health
Equity Ratio
62.7%
Return on Equity
-56.0%
ROCE
-88.9%
ROIC
-134.9%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-11.5m
EBIT
$-11.7m
Net Income
$-5.9m
Free Cash Flow
$-10.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
0.3%
EBIT
1.7%
Net Income
29.1%
Free Cash Flow
28.2%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow
-
More
EPS
$0.0
FCF per Share
$0.0
Short interest
3.2%
Employees
13
Rev per Employee
$0.0

Midatech Pharma Plc Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Midatech Pharma Plc Sponsored ADR forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Midatech Pharma Plc Sponsored ADR forecast:

Buy
86%
Hold
14%

Financial data from Midatech Pharma Plc Sponsored ADR

Jun '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.56 5.56
1% 1%
-
- Research and Development Expense 6.90 6.90
6% 6%
-
-12 -12
0% 0%
-
- Depreciation and Amortization 0.17 0.17
50% 50%
-
EBIT (Operating Income) EBIT -12 -12
2% 2%
-
Net Profit -5.85 -5.85
29% 29%
-

In millions USD.

Don't miss a Thing! We will send you all news about Midatech Pharma Plc Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Midatech Pharma Plc Sponsored ADR Stock News

Neutral
Accesswire
●
3 days ago
Today's interview with Stephen Stamp, CEO of Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) is about the Company's lead program, eRapa in Familial Adenomatous Polyposis (FAP), a genetic disease of the lower GI tract for which the only current remedy is surgical removal of the colon and/or rectum. Key takeaways: eRapa is an oral drug candidate designed to reduce or eliminate the need for surgical tre...
Neutral
GlobeNewsWire
●
11 days ago
Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds September 15, 2026 Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) (“Biodexa” or the “Company”), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announced that it has entered into a warrant exercise agreement with a...
Neutral
GlobeNewsWire
●
15 days ago
September 11, 2026 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2026 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers, today announces its unaudited interim results for the six months ended June 30, ...
More Midatech Pharma Plc Sponsored ADR News

Company Profile

Midatech Pharma Plc commercializes oncology treatments and cancer supportive care products through its U.S. commercial organization, Midatech Pharma US. The company engages in the development of pharmaceutical products utilizing its nanomedicine and sustained release technologies. Its pipeline includes MTD119, MTX102, MTD201 and MTX110. Midatech Pharma was founded on September 12, 2014 and is headquartered in Cardiff, the United Kingdom.

Head office United Kingdom
CEO Mr. Stamp
Employees 13
Founded 2000
Website www.biodexapharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today